EGFR and non-small cell lung carcinoma: Through precise retrieval using the keywords “LJF and cancer,” we identified a notable single-arm clinical study titled “A single-arm clinical study of LJF oral liquid in the treatment of non-small cell lung cancer EGFR-TKIs-associated oral mucositis” with the patent number ChiCTR2400080982.